Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 3
1949 1
1950 2
1951 1
1965 1
1966 1
1967 2
1968 2
1969 2
1970 3
1971 1
1972 7
1973 9
1974 4
1975 2
1976 6
1977 5
1978 18
1979 13
1980 6
1981 14
1982 7
1983 15
1984 9
1985 5
1986 15
1987 10
1988 11
1989 14
1990 23
1991 22
1992 25
1993 24
1994 35
1995 26
1996 33
1997 33
1998 51
1999 37
2000 31
2001 28
2002 17
2003 20
2004 20
2005 9
2006 11
2007 9
2008 8
2009 7
2010 8
2011 9
2012 10
2013 12
2014 9
2015 12
2016 10
2017 14
2018 19
2019 21
2020 13
2021 17
2022 13
2023 15
2024 13
2025 16
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

841 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.
Sandherr M, Schalk E, Heinz WJ, Köhler P, Krause SW, Liss B, Kausche L, Link H, Mellinghoff SC, Schmidt-Hieber M, Schuelper N, Spiekermann K, Sprute R, Seggewiss-Bernhardt R. Sandherr M, et al. Among authors: link h. Eur J Cancer. 2026 Feb 25;235:116244. doi: 10.1016/j.ejca.2026.116244. Epub 2026 Jan 16. Eur J Cancer. 2026. PMID: 41570611 Free article.
Native metabolomics identifies pteridines as CutA ligands and modulators of copper binding.
Wagner BC, Steuer-Lodd K, Geibel C, Stadelmann A, Rapp J, Link H, Schramm T, Boodaghian N, Hsiao A, Nussbaum E, Grenzendorfer HP, Albrecht R, Hartmann MD, Forchhammer K, Selim KA, Hughes CC, Petras D. Wagner BC, et al. Among authors: link h. Proc Natl Acad Sci U S A. 2025 Dec 2;122(48):e2509468122. doi: 10.1073/pnas.2509468122. Epub 2025 Nov 25. Proc Natl Acad Sci U S A. 2025. PMID: 41289401 Free PMC article.
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial.
Dührsen U, Bockisch A, Hertenstein B, Karsten IE, Kroschinsky F, Heuser M, Hochhaus A, Höffkes HG, Behringer D, Prange-Krex G, Tometten M, Grieshammer M, Grigoleit GU, Schmalz O, Jordan K, Bernhard H, Gaska T, Giagounidis A, Schroers R, Martens UM, Held G, Klapper W, Jöckel KH, Nonnemacher M, Hüttmann A; PETAL Trial Investigators. Dührsen U, et al. Blood Neoplasia. 2024 May 21;1(3):100018. doi: 10.1016/j.bneo.2024.100018. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453056 Free PMC article. Clinical Trial.
841 results